Taipei, Taiwan

Yung-Chieh Tseng



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Vaccine Development by Yung-Chieh Tseng

Introduction

Yung-Chieh Tseng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of virology, particularly in the development of methods for producing virus particles that can enhance vaccine efficacy. With a total of 2 patents, his work focuses on simplifying glycosylation profiles of viral proteins, which can lead to more effective vaccines.

Latest Patents

Tseng's latest patents include innovative methods for producing virus particles with simplified glycosylation of surface proteins. These methods target viral antigens, such as mono-glycosylated forms of HIV, HCV, Dengue virus, West Nile virus, and influenza virus. By utilizing these simplified glycosylation profiles, vaccines can be developed that are less sensitive to viral mutations. His patents also explore the use of glycosylation inhibitors to produce viruses or viral antigens with these simplified profiles, which can further enhance vaccine production.

Career Highlights

Yung-Chieh Tseng is affiliated with Academia Sinica, a leading research institution in Taiwan. His work has been instrumental in advancing the understanding of viral glycosylation and its implications for vaccine development. His innovative approaches have the potential to significantly impact public health by providing more robust vaccines against various viral infections.

Collaborations

Tseng has collaborated with notable researchers in his field, including Chi-Huey Wong and Che Ma. These collaborations have fostered a rich environment for innovation and have contributed to the advancement of vaccine technologies.

Conclusion

Yung-Chieh Tseng's contributions to the field of virology and vaccine development are noteworthy. His innovative methods for producing virus particles with simplified glycosylation profiles hold promise for creating more effective vaccines. His work continues to pave the way for advancements in public health and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…